Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
University of Lübeck · University Hospital Schleswig-Holstein · +12 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
566
total citations
- FWCI
- 62.50
- Percentile
- 100%
- References
- 35
Citations per year
Authors
21Topics & keywords
Topics
Keywords
- Eczema Area and Severity Index
- Dupilumab
- Medicine
- Atopic dermatitis
- Blinding
- Placebo
- Dermatology Life Quality Index
- Randomized controlled trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.